Increased oxidative stress in pre-eclamptic placenta is associated with altered proteasome activity and protein

R Hass1, C Sohn

  • 1Department of Biochemistry and Tumor Biology, Clinic of Obstetrics and Gynecology (OE6410), Medical School, Podbielskistr. 380, 30659 Hannover, Germany. hass.ralf@mh-hannover.de

Placenta
|October 29, 2003
PubMed

Insights

Pre-eclampsia is linked to a 30% increase in damaged placental proteins and a 30% decrease in proteasome function. This suggests impaired protein metabolism contributes to pre-eclampsia development.

Area of Science:

  • Biochemistry
  • Obstetrics
  • Proteomics

Background:

  • Oxidatively damaged proteins accumulate in pre-eclampsia.
  • The 20S proteasome metabolizes these damaged proteins.
  • Reduced proteasome function is implicated in pre-eclampsia.

Purpose of the Study:

  • To investigate the role of proteasome function and damaged protein levels in pre-eclampsia.
  • To explore molecular alterations in the proteasomal complex in pre-eclamptic placentas.

Main Methods:

  • Analysis of oxidatively damaged proteins in normal and pre-eclamptic placentas.
  • Evaluation of proteasome activity.
  • Two-dimensional SDS-PAGE and Western blotting for proteasome subunits and PP14.
  • Silver staining for differentially expressed proteins.

Main Results:

  • Pre-eclamptic placentas showed a 30% increase in damaged proteins and a 30% decrease in proteasome function.
  • Specific proteasome subunits (approx. 20 kDa and 30 kDa) were underexpressed in pre-eclamptic placentas.
  • Differential expression of acidic proteins (20-45 kDa) was observed between normal and pre-eclamptic placentas.

Conclusions:

  • Reduced proteasome activity contributes to the accumulation of damaged proteins in pre-eclampsia.
  • Alterations in the proteasomal complex and differential protein expression may underlie metabolic interference in pre-eclampsia.
  • These findings highlight potential molecular mechanisms contributing to pre-eclampsia pathogenesis.